ImmPACT Bio reels in $111M to prevent tumor escape with novel cell therapies

Despite the targeted approach of some cancer treatments, tumors can find ways to escape, leading patients to relapse. ImmPACT Bio will apply its Series B financing toward the development of cell therapies designed to prevent tumor escape.